News
HUM
178.83
+1.96%
3.43
Humana Is Maintained at Neutral by UBS
Dow Jones · 6h ago
Humana Price Target Cut to $195.00/Share From $285.00 by UBS
Dow Jones · 6h ago
UBS Maintains Neutral on Humana, Lowers Price Target to $195
Benzinga · 7h ago
Humana Analysts Slash Their Forecasts After Q4 Results
Benzinga · 7h ago
Midday Fly By: Cisco reports Q2 beat, Trump orders Pentagon to buy coal
TipRanks · 7h ago
Humana Cut to Sector Perform From Outperform by RBC Capital
Dow Jones · 8h ago
Humana Price Target Cut to $189.00/Share From $322.00 by RBC Capital
Dow Jones · 8h ago
RBC Capital Downgrades Humana to Sector Perform, Lowers Price Target to $189
Benzinga · 8h ago
Humana Is Maintained at Buy by Guggenheim
Dow Jones · 8h ago
Humana Price Target Cut to $252.00/Share From $312.00 by Guggenheim
Dow Jones · 8h ago
Guggenheim Maintains Buy on Humana, Lowers Price Target to $252
Benzinga · 8h ago
Humana Is Maintained at Neutral by Cantor Fitzgerald
Dow Jones · 9h ago
Humana Price Target Cut to $201.00/Share From $290.00 by Cantor Fitzgerald
Dow Jones · 9h ago
Cantor Fitzgerald Maintains Neutral on Humana, Lowers Price Target to $201
Benzinga · 9h ago
Jefferies Reaffirms Their Buy Rating on Humana (HUM)
TipRanks · 10h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Humana (HUM)
TipRanks · 10h ago
Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls
TipRanks · 10h ago
Humana price target lowered to $195 from $285 at UBS
TipRanks · 10h ago
UBS Keeps Their Hold Rating on Humana (HUM)
TipRanks · 10h ago
Humana price target lowered to $196 from $260 at BofA
TipRanks · 10h ago
More
Webull provides a variety of real-time HUM stock news. You can receive the latest news about Humana through multiple platforms. This information may help you make smarter investment decisions.
About HUM
Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.